Prothena Corporation plc (PRTA)
NASDAQ·Healthcare·Biotechnology
$8.95
-0.78%
Mkt Cap $472.23M
Analyst Ratings
No recent rating data.
Price Target (15 analysts)
$24.50
Range $19.00 – $30.00
Implied Upside
+173.7%
Consensus $24.50 vs current $8.95
NASDAQ·Healthcare·Biotechnology
$8.95
-0.78%
Mkt Cap $472.23M
No recent rating data.
Price Target (15 analysts)
$24.50
Range $19.00 – $30.00
+173.7%
Consensus $24.50 vs current $8.95